Brostallicin Clinical Trial for Myxoid Liposarcoma
NCT00633165
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Myxoid Liposarcoma
Interventions
DRUG:
Brostallicin
Sponsor
Systems Medicine LLC